Posts

Showing posts with the label Electrophysiology Devices Market

Electrophysiology Devices Market 2030: Trends Driving Cardiac Care Forward

Image
Electrophysiology Devices Market Trends The global electrophysiology devices market size was estimated at USD 10.07 billion in 2023 and is expected to grow at a CAGR of 15.1% from 2024 to 2030. Increasing use of electrophysiology (EP) tests in the treatment and diagnosis of heart diseases, such as atrial fibrillation, growing demand for devices for cardiac rhythm management for constant monitoring, and increasing application of these devices in out-of-hospital settings are propelling the industry growth. The prevalence of heart failure, cardiac arrest, and atrial fibrillation among millennials is rising due to sedentary lifestyles, smoking, excessive alcohol consumption, and others. According to the CDC, approximately 12.1 million Americans will be suffering from atrial fibrillation by 2030. The growing number of catheter ablation procedures is expected to positively impact the electrophysiology devices market. As the number of ablation procedures rises, a direct increase in demand ...

Electrophysiology Devices Market 2030: Key Trends Driving Growth and Adoption

Image
Electrophysiology Devices Market Growth & Trends The global  electrophysiology devices market  size is expected to reach USD 30.1 billion by 2030, expanding at a CAGR of 15.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The demand for electrophysiology procedures is expected to increase owing to the growing geriatric population and frequent cardiac arrhythmias incidents. According to the World Health Organization, the population aged 60 years and above was approximately 1 billion in 2020 and is expected to reach 1.4 billion by 2030. The adoption of diagnostics and ablation techniques among medical professionals has resulted in the high usage of EP products in the past few years and is likely to drive market growth. The development of new products, such as Nanostim-dual-chamber leadless pacemakers, is anticipated to fuel demand for EP products. Cardiac ablation has gained popularity as the first-line treatment, rendering a 95% success ra...